UPNEEQ 30 Vials ( 30 Supply)

PNEEQ 30 Day Supply is a clinically formulated product designed to elevate upper eyelids and enhance overall eye appearance. Suitable for daily use, it provides visible results within minutes, promoting a more youthful look. This supply ensures consistent application for optimal effectiveness over a 30-day period.

This product requires a telemedicine appointment which we offer for free through our telemedicine partner My Doctor's Live. After you complete your purchase, we will reach out to you about scheduling a quick 5 minute telemedicine appointment. To learn more about My Doctor's Live, please visit My Doctor's Live | Totality Skincare (totality-skincare.com). If after the purchase is made it is determined that you are not eligible for this product, we will cancel your order and issue a full refund.

Totality Medispa and Skincare is an authorized provider of Upneeq ®!

Imagine an eye-opening lift with just one daily drop.

Upneeq ® is the only FDA-approved eye drop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.

Skip the trip to the doctor's office! Your telemedicine appointment is included with your purchase if you are deemed a good candidate.

Apply one drop of Upneeq ® per eye, once a day. You'll see a visible difference in as little as two hours. Many patients experience visible results as soon as 15 minutes after application! 

CONTAINS 45 SINGLE PATIENT-USE

(.3 ML) IN EACH INDIVIDUAL FOIL POUCHES

Product is non refundable 

What is UPNEEQ?

UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is an eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.

How Do I Apply Upneeq?

Apply Upneeq to your affected eye(s) in 2 easy steps

Step 1: Cut open foil wrapper and remove single-use vial

Step 2: Apply one drop of Upneeq in each affected eye as directed, once a day

Do not let the tip of the vial touch your eye or any other surface

Vials should not be re-used after opening and should be thrown away after applying drop(s)

If you wear contact lenses, remove them before applying Upneeq eyedrops

You may put them back in 15 minutes after applying Upneeq

If more than one topical ophthalmic drug is being used, the drugs should be administered at least 15 minutes between applications

Upneeq should only be used as directed

Upneeq is designed to only be applied as an eyedrop

Each vial contains enough Upneeq solution to allow for one drop in each affected eye

The solution should never be swallowed or ingested in any other way

Storage requirements: Upneeq should be stored at 68°F-77°F (20°C-25°C) and should be protected from excessive heat

Keep out of reach of children

 What warnings and precautions are associated with UPNEEQ?

Low-lying lids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability to move eye muscles, eye infection and eye tumors. Tell your doctor if you have any of these conditions.

UPNEEQ is a type of medication that may affect your blood pressure. If you have heart disease, uncontrolled high or low blood pressure, or feel faint at rest or when quickly standing up, you should call your doctor if your symptoms get worse.

Patients with reduced blood flow to the brain or heart, or patients who experience eye or mouth dryness due to an immune system disorder (Sjögren’s syndrome), should use care when taking UPNEEQ. Call your doctor immediately if you feel your symptoms may be getting worse.

UPNEEQ may increase the risk of eye pressure due to fluid buildup (angle-closure glaucoma) in patients with untreated narrow-angle glaucoma. Call your doctor immediately if you feel increased pressure in your eye after using UPNEEQ.

Do not let the tip of the UPNEEQ vial touch your eye or any other surface. This can help prevent eye injury or contamination. Each UPNEEQ vial is for one-time use and should be discarded after being used.

What are the most common side effects of UPNEEQ?

The most common adverse reactions with UPNEEQ (occurring in 1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.